Berkay Kılıç

Araştırma Portfolyosu

https://scholar.google.com/citations?hl=tr&user=ZQvO2YIAAAAJ

Yazarlık Yaptığı Örnek Makaleler

Kilic, B., Guler, Y., Azman, F. N., Bostanci, E., & Ugurlu, S. (2024). Efficacy and safety of anti-interleukin-1 treatment in familial Mediterranean fever patients: a systematic review and meta-analysis. Rheumatology, 63(4), 925-935.

Ipek, Y., Kilic, B., Gunay, U. B., & Eskazan, A. E. (2023). Novel janus-kinase (jak) inhibitors in myelofibrosis. Expert Opinion on Investigational Drugs, 32(10), 931-940.

Kilic, B., Ozturk, A., Karup, S., Hacioglu, E., & Ugurlu, S. (2025). Efficacy and safety of biologic drugs in Still’s disease: a systematic review and network meta-analysis of randomized controlled trials. Rheumatology, 64(1), 22-31.

Kilic, B., Sacin, E., Tanin, M. K., Kilinc, O. C., & Ugurlu, S. (2025). Emerging treatment approaches for VEXAS syndrome: a systematic review and meta-analysis. Annals of Hematology, 1-14.

Kilic, B., Parlar, K., Karup, S., Ozturk, A., Karaahmetli, K., & Ugurlu, S. (2025). Anakinra in the management of adult-onset still’s disease: a single-center experience. Internal and Emergency Medicine, 20(1), 131-138.